Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions, methods of administration and uses for trivalent dengue virus formulations

Compositions, methods of administration and uses for trivalent dengue virus formulations

US Patent 9878031 · Granted Jan 30, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for dengue virus chimeric constructions in vaccines2025
Coronavirus vaccine comprising a mosaic protein2024
Compositions and methods for dengue virus chimeric constructions in vaccines2024
Methods and compositions for live attenuated viruses2021
Methods and compositions for live attenuated viruses2021
Multi-valent human immunodeficiency virus antigen binding molecules and uses the2021
Compositions, methods and uses for dengue virus serotype-4 constructs2021
Compositions, methods and uses for dengue virus serotype-4 constructs2021
Compositions and methods for live, attenuated alphavirus formulations2020
Hand, foot, and mouth vaccines and methods of manufacture and use thereof2020
Hand, foot, and mouth vaccines and methods of manufacture and use thereof2020
Broadly reactive mosaic peptide for influenza vaccine2020